Civilization Ventures

Civilization Ventures invests in visionary founders who are leading the future of health tech and biology-driven innovation. We aim to be the first check and lead investor in highly disruptive companies in synthetic biology and exponential health tech (genomics, diagnostics, digital health, AI, personalized and regenerative medicine). Our team comprises serial entrepreneurs and industry thought leaders who work tirelessly to help each of our portfolio companies succeed. At CV, we champion visionary founders tackling the most critical challenges in biology and healthcare. With a portfolio worth $9.7B, encompassing 64 companies and 9 successful exits, we provide the capital and resources necessary for innovators to thrive.